Upload
tianna-hilling
View
216
Download
0
Tags:
Embed Size (px)
Citation preview
Patient-Reported Questionnaires in Clinical Practice: Just Another Laboratory Test
David Cella, Ph.D.Professor and Chair
Department of Medical Social SciencesFeinberg School of Medicine
Health Reform 2010
• Major Commitment of the Obama Administration
• Sweet Spot:• Right treatment to the right people• Avoid unnecessary / inappropriate
treatments• Universally available and affordable
• Chronic diseases• Major expense• Rarely “cured”• Most important outcome is often quality of
life
Health care providers do not routinely use health-related quality of life (HRQL) data to guide diagnosis, treatment, or performance improvement.
…if they did, would it make a difference?
…how should HRQL data be presented?
The Problem
Measurement Science: Not the Problem
In chronic illness care, the problem is not the lack of HRQL measures • a large selection of generic and
disease-specific measures exist
The problem is the unhelpful way the data are presented to clinicians
5
Continuum of Disease-specific and Generic Health Measures
5
Clinical Markers
Specific Symptoms
Impact of Disease-specific
Problems
Generic Functioning,
Well-being and Evaluation
Adapted from: Wilson and Cleary, JAMA, 1995 Ware, Annual Rev. Pub. Health, 1995
(1) (2) (3) (4)
66
Clinical Markers
Specific Symptoms
Impact of Disease-specific
Problems
Generic Functioning,
Well-being and Evaluation
Adapted from: Wilson and Cleary, JAMA, 1995 Ware, Annual Rev. Pub. Health, 1995
(1) (2) (3) (4)
dd
Spirometry
Over the last 4 weeks I have had shortness of breath Almost every day Several days a week A few days a month Not at all
Shortness of Breath
Continuum of Disease-specific and Generic Health Measures
77
Clinical Markers
Specific Symptoms
Impact of Disease-specific
Problems
Generic Functioning,
Well-being and Evaluation
Adapted from: Wilson and Cleary, JAMA, 1995 Ware, Annual Rev. Pub. Health, 1995
(1) (2) (3) (4)
dd
Over the last 4 weeks I have had shortness of breath Almost every day Several days a week A few days a month Not at all
How much did your lung/respiratory problems limit your usual activities or enjoyment of everyday life? Not at all A little Moderately Extremely
Spirometry Shortness of Breath
Respiratory-specific
Continuum of Disease-specific and Generic Health Measures
88
Clinical Markers
Specific Symptoms
Impact of Disease-specific
Problems
Generic Functioning,
Well-being and Evaluation
Adapted from: Wilson and Cleary, JAMA, 1995 Ware, Annual Rev. Pub. Health, 1995
(1) (2) (3) (4)
dd
Over the last 4 weeks I have had shortness of breath Almost every day Several days a week A few days a month Not at all
How much did your lung/respiratory problems limit your usual activities or enjoyment of everyday life? Not at all A little Moderately Extremely
In general, would you say your health is…
Excellent Very good Good Fair Poor
Spirometry Shortness of Breath
Respiratory-specific
Generic
Continuum of Disease-specific and Generic Health Measures
Can Patient Reported Outcomes (PROs) be Treated as Just Another
Lab Result?
9
10
What Do We Need to Launch a Useful Clinical PRO Lab
• Outcomes that matter to patients and providers
• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation• Reference values / normal ranges
SyMon-L Symptoms Tracked• Pain• Fatigue (lack of energy)• Shortness of breath• Coughing• Chest tightness• Difficulty breathing• Nausea• Poor appetite• Weight loss• Bothered by treatment side effects• Emotional distress• Cognitive dysfunction• Dissatisfaction with HRQL
Symptom Summary Report
Results: Clinical intervention responses to symptom alerts
Types of intervention N %
Medical/clinical (e.g., medications, MD appt) 233 20%
Education 420 36%
Support, coping 455 39%
Coordination of care (e.g., referrals) 50 4%
Acuity of Interventions
Critical (e.g., PE, ER visit, admission) 22 3%
Important (e.g., change in meds, clinic visit, IV therapy) 103 16%
Standard of care (e.g., reassessment, education) 374 59%
Non-essential (e.g., follow-up) 98 15%
System-related (e.g., study questions) 37 6%
Symptom Monitoring Report
QoL predicts survival in NSCLCStudy What predicts?
Stanley (1980) Initial PS
Kaasa, Mastekaasa & Lund (1989) General sx (pain, fatigue)Psychosocial well being
Ganz et al. (1991) Overall QoL
Loprinzi et al. (1994) Physician-rated PSPatient-rated PS
Ruckdeschel (1994) Patient-reported QOL
Herndon et al. (1999) Pain
Montazeri et al. (2001) Pre-diagnosis overall QoL
Eton et al (2003) Patient-reported QoL
Symptoms(LCS)
Emotional
Physical
Social
Functional
Quality of Life FACT-L
Baseline patient characteristics predicting survival
Order of entry
FACT TOIMetastatic symptomsECOG PSStage (IIIB vs IV)Paclitaxel (Arm A vs B/C)
Risk ratio*
0.981.441.571.390.81
p value
<0.001<0.001<0.0010.0160.039
*Risk of deathOther possible explanatory variables included age, sex, g-csf, weight loss, disease symptoms, systemic symptoms, comorbidity and other FACT subscales
<58, no
<58, yes
>58, no
>58, yes
Initial, improved?
Proportion surviving
1.0
0.8
0.6
0.4
0.2
0.00 1 2 3 4 5 6 7 8 9 10 11 12
Initial TOI and improvement at 6 weeks* (n=352)
*Patients with missing QoL excluded
Eton et al, JCO, 2003
LCS Mean Change By WeekBy Objective Response, Trial 39
PRSDPD
LCS
Sco
re C
hang
e
-8
-6
-4
-2
0
2
4
6
8
10
12
14
16
Weeks from Randomization0 2 4 6 8 10 12 14 16 18 20 22 24 26
Survival by Disease-related Symptom ImprovementSubset surviving > 8 weeks
At Risk Failures Medianin Months
Yes 84 35 .No 100 85 4.8
Prob
abili
ty
0.0
0.2
0.4
0.6
0.8
1.0
Months from Randomization
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Survival by Response & Symptom ImprovementSubset surviving > 8 weeks
At Risk Failures Medianin Months
PR 22 3 .LCS imp. 84 35 .Other 99 85 4.8
Prob
abili
ty
0.0
0.2
0.4
0.6
0.8
1.0
Months from Randomization
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Survival by Symptom Improvement in SD SubsetSubset surviving > 8 weeks *
* All patients with an objective response of SD survived > 8 weeks.
At Risk Failures Medianin Months
SD + LCS imp. 44 19 .SD 62 32 9.4SD - LCS imp. 18 13 4.6
Prob
abili
ty
0.0
0.2
0.4
0.6
0.8
1.0
Months from Randomization
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
23
Content of Widely-Used Patient-Reported Outcome Measures
Source: Adapted from Ware, 1995
Reported health transition l l l
SIP = Sickness Impact Profile (1976)HIE = Health Insurance Experiment surveys (1979)NHP = Nottingham Health Profile (1980)QLI = Quality of Life Index (1981)COOP = Dartmouth Function Charts (1987)DUKE = Duke Health Profile (1990)MOS FWBP = MOS Functioning and Well-Being
Profile (1992)
MOS SF-36 = MOS 36-Item Short-Form Health Survey (1992)
QWB = Quality of Well-Being Scale (1973)EUROQOL = European Quality of Life Index (1990)HUI = Health Utility Index (1996)SF-6D = SF-36 Utility Index (Brazier, 2002)
Psychometric Utility RelatedSIP HIE NHP COOP DUKE MOS
FWBPMOSSF-36
QWB EURO-QOL
HUI SF-6DCONCEPTS
Physical functioning l l l l l l l l l l lSocial functioning l l l l l l l l l lRole functioning l l l l l l l l l lPsychological distress l l l l l l l l l lHealth perceptions (general) l l l l l lPain (bodily) l l l l l l l l lEnergy/fatigue l l l l l l lPsychological well-being l l l lSleep l l l lCognitive functioning l l l lQuality of life l l l
PROMIS = Patient Reported Outcomes Measurement Information System
= Quality of Well-Being Scale (1973)
PROMIS
llll
ll
l
PROMIS integrates the fields of…
InformationTechnology
PROMIS
QualitativeResearch
SurveyResearch
Psychometrics
Psycho-metricTesting
Item Bank(IRT-calibrated items reviewed forreliability, validity, and sensitivity)
0.0
0.5
1.0
1.5
2.0
2.5
-3 -2 -1 0 1 2 3
Theta
Info
rmati
on
0.0
0.2
0.4
0.6
0.8
1.0
-3 -2 -1 0 1 2 3
Theta
Pro
ba
bil
ity o
f R
esp
on
se
Short FormInstruments
CAT
Items fromInstrument
A
Item Pool
Items fromInstrument
B
Items fromInstrument
C
NewItems
Questionnaireadministered to largerepresentative sample
SecondaryData Analysis
CognitiveTesting
FocusGroups
Content ExpertReview
Self-reported Health
Mental Health
Physical Health
Social Health
Physical Function*
Symptoms
Emotional Distress
Cognitive Function
Social Function
Positive Psychological
Function
Social Relationships
Upper Extremities: dexterity
Lower Extremities: mobility
Central: neck and back
Activities: Instrumental Activities of Daily Living
Pain
Fatigue*
Other
Quality
Behavior
Impact*
Experience
Impact
Anxiety*
Depression*
Anger
Substance Abuse
Negative Impact of Illness
Alcohol Abuse
Positive Impact of Illness
Mastery & Control (self-efficacy)
Subjective Well-Being (positive affect)
Ability to Participate*
Satisfaction with Participation*
SatisfactionSatisfaction
Satisfaction
Satisfaction
Meaning & Spirituality
Stress Response
Self-concept
Sleep/Wake Function*
Sexual Function
Social Roles
Discretionary Social Activities
Social Roles
Discretionary Social Activities
Meaning & Spirituality
Coping
Self-concept
Social Connection
Social Isolation
Social Isolation
Quantity of Social Support (Integration)
Quality of Social SupportInstrumental/Informational
Companionship
Emotional Support
Sleep Disturbance
Wake Disturbance
CaPS bank in development
PROMIS v1.0 bank
PROMIS area tested but no bank developed for v1.0
Area addressed (in part) by bank within lineage
Area not addressed yet
* = Additional cancer-specific PROMIS bank
PROMIS Domain Framework
27
What Do We Need to Launch a Useful
Clinical PRO Lab?
• Outcomes that matter to patients and providers
• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation• Reference values / normal ranges
PROMIS Profile Short Forms
28* reduced set (the full bank has 112 items) was used for real data simulation purposes
Anxiety29
Depression28
Fatigue95
Pain Impact41
Sleep Disturbance
27
Physical Function86*
Social Role14
46
8
Mental
Physical
Social
PROMIS Profile Short Forms
29
PROMIS Profile Subscales: Test Information Functions
Anxiety
T-score
rel.=.90
rel.=.95
0
5
10
15
20
25
10 30 50 70 90
Depression
T-score
rel.=.90
rel.=.95
0
10
20
30
10 30 50 70 90
Fatigue
T-score
rel.=.90
rel.=.95
0
10
20
30
10 30 50 70 90
Pain Impact
T-score
rel.=.90
rel.=.95
0
10
20
30
40
50
60
10 30 50 70 90
Physical Function
T-score
rel.=.90
rel.=.95
0
10
20
30
40
10 30 50 70 90
Sleep Disturbance
T-score
rel.=.90
rel.=.95
0
5
10
15
10 30 50 70 90
Social Role
T-score
rel.=.90
rel.=.95
0
10
20
30
40
10 30 50 70 90
SF 8SF 6SF 4
30
PROMIS Profile Subscales: Correlations with Full Banks
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Anxiety
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Depression
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Fatigue
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Pain Impact
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Physical Function
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Sleep Disturbance
Length
Cor
rela
tion
1 2 3 4 5 6 7 8
0.80
0.85
0.90
0.95
1.00
Social Role
Length
Cor
rela
tion
32
“Ceiling Effect”
• Outcomes that matter to patients and providers
• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation• Reference values / normal ranges
What Do We Need to Launch a Useful
Clinical PRO Lab?
PROMIS-57 Profile by General Health Rating:In general, would you say your health is:
33
3040
5060
7080
Full Bank
T-S
core
8070
6050
4030
AN
X
DE
P
FA
T
PA
I
SLP
PH
F
SO
R
PoorFairGoodVery goodExcellent
3040
5060
7080
SF - 8 Items
In general, w ould you say your health is:
T-S
core
8070
6050
4030
AN
X
DE
P
FA
T
PA
I
SLP
PH
F
SO
R
PoorFairGoodVery goodExcellent
3040
5060
7080
SF - 6 Items
T-S
core
8070
6050
4030
AN
X
DE
P
FA
T
PA
I
SLP
PH
F
SO
R
PoorFairGoodVery goodExcellent
3040
5060
7080
SF - 4 Items
T-S
core
8070
6050
4030
AN
X
DE
P
FA
T
PA
I
SLP
PH
F
SO
R
PoorFairGoodVery goodExcellent
PROMIScore - PSF
34
35
• Outcomes that matter to patients and providers
• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation• Reference values / normal ranges
What Do We Need to Launch a Useful Clinical PRO Lab?
g
0
0.1
0.2
0.3
0.4
0.5
0.6
-2.5 -1.5 -0.5 0.5 1.5 2.5
Computerized Adaptive Testing (CAT)
• Estimates location (severity; capability) of a person on a domain (concept) by selecting questions based on that person’s prior answers
• Iteratively estimates a person’s standing on the domain (e.g., depressive symptoms) and administers only the most informative items, achieving precision with a minimum possible number of questions.
Beginning of CAT
01
23
45
Item 15
T-ScoreIn
form
atio
n
20 30 40 50 60 70 80
|
Max at T-Score=56
20 40 60 80
T-Score
Po
ste
rio
r D
istr
ibu
tion
20 30 40 50 60 70 80
T-Score = 50 SE = 10
Items Administered
T-S
core
0 1 2 3 4 5 6 7 8
20
30
40
50
60
70
80 Items: 15
T-Score: 50 SEM: 10
Best Item-I felt depressed
0.0
0.2
0.4
0.6
0.8
1.0
Item 15
T-Score
Pro
ba
bili
ty
20 30 40 50 60 70 80
12345
20 40 60 80
T-Score
Po
ste
rio
r D
istr
ibu
tion
20 30 40 50 60 70 80
I felt depressed1. Never2. Rarely3. Sometimes4. Often5. Always
T-Score = 52 SE = 4
Items Administered
T-S
core
0 1 2 3 4 5 6 7 8
20
30
40
50
60
70
80 Items: 15
T-Score: 52 SEM: 4 01
23
45
Item 10
T-ScoreIn
form
atio
n
20 30 40 50 60 70 80
|
Max at T-Score=57
Next Best Item-I felt like a failure
0.0
0.2
0.4
0.6
0.8
1.0
Item 10
T-Score
Pro
ba
bili
ty
20 30 40 50 60 70 80
12345
I felt like a failure1. Never2. Rarely3. Sometimes4. Often5. Always
T-Score = 53 SE = 3
Items Administered
T-S
core
0 1 2 3 4 5 6 7 8
20
30
40
50
60
70
80 Items: 15,10
T-Score: 53 SEM: 3 01
23
45
Item 1
T-ScoreIn
form
atio
n
20 30 40 50 60 70 80
|
Max at T-Score=59
Next Best Item-I felt worthless
0.0
0.2
0.4
0.6
0.8
1.0
Item 1
T-Score
Pro
ba
bili
ty
20 30 40 50 60 70 80
12345
20 40 60 80
T-Score
Po
ste
rio
r D
istr
ibu
tion
20 30 40 50 60 70 80
I felt worthless1. Never2. Rarely3. Sometimes4. Often5. Always
T-Score = 55 SE = 2
Items Administered
T-S
core
0 1 2 3 4 5 6 7 8
20
30
40
50
60
70
80 Items: 15,10,1
T-Score: 55 SEM: 2 01
23
45
Item 3
T-ScoreIn
form
atio
n
20 30 40 50 60 70 80
|
Max at T-Score=58
Next Best Item-I felt helpless
0.0
0.2
0.4
0.6
0.8
1.0
Item 3
T-Score
Pro
ba
bili
ty
20 30 40 50 60 70 80
12345
20 40 60 80
T-Score
Po
ste
rio
r D
istr
ibu
tion
20 30 40 50 60 70 80
I felt that nothing could cheer me up1. Never2. Rarely3. Sometimes4. Often5. Always
T-Score = 55 SE = 2
Items Administered
T-S
core
0 1 2 3 4 5 6 7 8
20
30
40
50
60
70
80 Items: 15,10,1,3,21,2,5
T-Score: 55 SEM: 2
20 40 60 80
T-Score
Po
ste
rio
r D
istr
ibu
tion
20 30 40 50 60 70 80
IRT expands the range of what we can measure
Rose et al, J Clin Epidemiol 2007 (accepted)
SE = 0.32rel = 0.90
SE = 0.22rel = 0.95
0
0.1
0.2
0.3
0.4
0.5
0.6
0 10 20 30 40 50 60 70 80
SF-36 items
CAT 10 itemsFull Item Bank
measurement precision (standard error)
normed theta values
HAQ items
SF-12 items
representativesample
rheumatoid arthritis patients
US-Representative Sample
0.4
0.5
0.3
0.2
0.1
-4 -3 -2 -1 0 +1 +2
PROMIS Fatigue Short Form
Garcia SF et al, J Clin Onc, 2007. © 2007 Reprinted with permission of the PROMIS Health Organization and the PROMIS Cooperative Group
In the past 7 days … Never Rarely Some-times
Often Always
FATEXP 20
How often did you feel tired? 1
2
3
4
5
FATEXP 5
How often did you experience extreme exhaustion? 1
2
3
4
5
FATEXP 18
How often did you run out of energy? 1
2
3
4
5
FATIMP 33
How often did your fatigue limit you at work (include work at home)?
1
2
3
4
5
FATIMP 30
How often were you too tired to think clearly? 1
2
3
4
5
FATIMP 21
How often were you too tired to take a bath or shower? 1
2
3
4
5
FATIMP 40
How often did you have enough energy to exercise strenuously?
1
2
3
4
5
0
0.1
0.2
0.3
0.4
0.5
0.6
-2.5 -1.5 -0.5 0.5 1.5 2.5
7-item Short-form7-item CAT
98-item Bank
No Fatigue Severe Fatigue
SE=0.32 (r=0.90)
SE=0.22 (r=0.95)
Comparison of Measurement PrecisionFull-length Item Bank vs. Legacy vs. CAT vs. Short-form
Sta
ndar
d E
rror
45
CAT
Assess Health Dynamically When Necessary
Patient scores
here
CAT = Computerized Adaptive Testing
46
• Outcomes that matter to patients and providers
• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation• Reference values / normal ranges
What Do We Need to Launch a Useful
Clinical PRO Lab?
47
We Need the Health Equivalent of a
Two-Sided Tape Measure
52 centimeters = 20.5 inches
…and easy-to-use conversion tables with reference data and action thresholds
PROMIS Depression Bank and CES-D
Depression
CE
SD
-2 -1 0 1 2 3 4
01
02
03
04
05
06
0
r =0.84
-2 -1 0 1 2 3 4
08
0
Depression
Depression
CE
SD
-2 -1 0 1 2 3 4
01
02
03
04
05
06
0
01
02
03
04
05
06
0
0 100 250
CE
SD
Fatigue
• Experience and Impact• 95-item bank
• Legacy Instruments• SF-36 Vitality Scale (4 items)
• FACIT-Fatigue Scale (13 items)
0
0.1
0.2
0.3
0.4
0.5
0.6
-2.5 -1.5 -0.5 0.5 1.5 2.5
4-item SF36/Vitality4-item CAT
13-item FACIT-Fatigue13-item CAT98-item Bank
No Fatigue Severe Fatigue
SE=0.32 (r=0.90)
SE=0.22 (r=0.95)
Comparison of Measurement PrecisionFull-length Item Bank vs. Legacy vs. CAT vs. Short-form
Sta
ndar
d E
rror
52
What do the results mean?
• Outcomes that matter to patients and providers• Practical (brief) and inexpensive• Covers a range, including normal• Greater precision• Comparability of scores• Ease of interpretation
• Reference values / normal ranges
What Do We Need to Launch a Useful
Clinical PRO Lab?
53
What Does a Change in Score Mean?
30 40 50
Chronic Lung Disease
Physical Component Summary (PCS)
DiabetesType II
Congestive Heart Failure
Average Adult
Asthma After
Rx
Asthma Before
Rx
Treatment
Average Well Adult
50% reduction in disease burden 33% reduction in hospitalization Substantial increase in work productivity Subsequent cost savings
LowLow HighHigh
PRO Bank Person ScorePRO Bank Person Score
Interpretation AidsInterpretation Aids
Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q Q Q Q Q Q Q Q Likely Likely UnlikelyUnlikely
Item LocationItem Location
Q Q QQ Q QQ Q QQ Q Q Q Q QQ Q Q
Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q QQ Q QQ Q Q
Q Q QQ Q QQ Q QQ Q QQ Q QQ Q Q
Q Q Q Q
Q Q Q Q
Q Q Q Q
People and Items Distributed on the Same Metric: FatiguePeople and Items Distributed on the Same Metric: Fatigue
0.0
Ceiling effect
0.0
Ceiling effect
People with more fatigue
Items less likely to be endorsed
Items more likely to be endorsed
People with less fatigue
LowLow HighHigh
PRO Bank Person ScorePRO Bank Person Score
Interpretation AidsInterpretation Aids
Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q Q Q Q Q Q Q Q Likely Likely UnlikelyUnlikely
Item LocationItem Location
Q Q QQ Q QQ Q QQ Q Q Q Q QQ Q Q
Q Q QQ Q Q Q Q QQ Q Q Q Q QQ Q QQ Q QQ Q Q
Q Q QQ Q QQ Q QQ Q QQ Q QQ Q Q
Q Q Q Q
Q Q Q Q
Q Q Q Q
LowLow HighHigh
PRO Bank Person ScorePRO Bank Person Score
Interpretation AidsInterpretation Aids
30 40 50 60 70
M = 50, SD = 10
LowLow HighHigh
Interpretation Aids: Cancer example
Interpretation Aids: Cancer example
Fatigue Score=60Fatigue Score=60
30 40 50 60 70
This patient’s fatigue score is 60, significantly worse than average (50). Cancer patients who score 60 on fatigue tend to answer questions as follows:
…”I have been too tired to climb one flight of stairs: VERY MUCH
…”I have had enough energy to go out with my family: A LITTLE BIT
Click here if you would like to see this patient’s individual answers
LowLow HighHigh
Interpretation Aids: Cancer example
Interpretation Aids: Cancer example
Fatigue Score=40Fatigue Score=40
30 40 50 60 70
This patient’s fatigue score is 40, significantly better than average (50). People who score 40 on fatigue tend to answer questions as follows:
…”I have been too tired to climb one flight of stairs: SOMEWHAT…”I have had enough energy to go out with my family: VERY MUCH
Click here if you would like to see this patient’s individual answers
60
How Long Per Concept? It depends
• Population monitoring • 1-2 questions
• Group-level outcomes monitoring • 5-7 questions
• Patient-level measurement/management• 10-12 questions or CAT
61
Matching Methods to Applications
1
2
3
4
5
6
7
1
3
5
7
Single-Item
1
2
3
4
5
Multi-ItemScale
PopulationMonitoring
Group-LevelOutcomesMonitoring
Patient-LevelManagement
“Item Pool” (CAT Dynamic)
7
6
Most Functionally Impaired
NoisyIndividual
Classification
Very AccurateIndividual
Classification
www.nihpromis.org
PROMIS Family of Delivery Platforms (2009 )
InteractiveVoice
Recognition
InternetAdministered
Personal Interview
Self Administered
Telephone Interview
Hand-held
Device
MultipleAssessment
Options
TV
Conclusions• Patient-reported outcomes are:
• Well characterized• Easily measured• Increasingly interpretable• Rarely used in Clinical Practice
• Going forward, clinician engagement is the key to setting and applying outcome targets and practice standards